181 related articles for article (PubMed ID: 17626243)
1. Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells.
Rubinek T; Chesnokova V; Wolf I; Wawrowsky K; Vlotides G; Melmed S
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C1082-92. PubMed ID: 17626243
[TBL] [Abstract][Full Text] [Related]
2. Diminished pancreatic beta-cell mass in securin-null mice is caused by beta-cell apoptosis and senescence.
Chesnokova V; Wong C; Zonis S; Gruszka A; Wawrowsky K; Ren SG; Benshlomo A; Yu R
Endocrinology; 2009 Jun; 150(6):2603-10. PubMed ID: 19213844
[TBL] [Abstract][Full Text] [Related]
3. Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.
Chesnokova V; Zonis S; Rubinek T; Yu R; Ben-Shlomo A; Kovacs K; Wawrowsky K; Melmed S
Cancer Res; 2007 Nov; 67(21):10564-72. PubMed ID: 17975001
[TBL] [Abstract][Full Text] [Related]
4. Separase, securin and Rad21 in neural cell growth.
Pemberton HN; Franklyn JA; Boelaert K; Chan SY; Kim DS; Kim C; Cheng SY; Kilby MD; McCabe CJ
J Cell Physiol; 2007 Oct; 213(1):45-53. PubMed ID: 17450531
[TBL] [Abstract][Full Text] [Related]
5. p21(Cip1) restrains pituitary tumor growth.
Chesnokova V; Zonis S; Kovacs K; Ben-Shlomo A; Wawrowsky K; Bannykh S; Melmed S
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17498-503. PubMed ID: 18981426
[TBL] [Abstract][Full Text] [Related]
6. Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells.
Yu R; Cruz-Soto M; Li Calzi S; Hui H; Melmed S
J Endocrinol; 2006 Oct; 191(1):45-53. PubMed ID: 17065388
[TBL] [Abstract][Full Text] [Related]
7. Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis.
Chesnokova V; Kovacs K; Castro AV; Zonis S; Melmed S
Mol Endocrinol; 2005 Sep; 19(9):2371-9. PubMed ID: 15919720
[TBL] [Abstract][Full Text] [Related]
8. Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes.
Wang Z; Moro E; Kovacs K; Yu R; Melmed S
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3428-32. PubMed ID: 12626748
[TBL] [Abstract][Full Text] [Related]
9. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division.
Wang Z; Yu R; Melmed S
Mol Endocrinol; 2001 Nov; 15(11):1870-9. PubMed ID: 11682618
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of pituitary tumor transforming gene in tumorigenesis.
Tfelt-Hansen J; Kanuparthi D; Chattopadhyay N
Clin Med Res; 2006 Jun; 4(2):130-7. PubMed ID: 16809406
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the anaphase-promoting complex-separase cascade by transforming growth factor-beta modulates mitotic progression in bone marrow stromal cells.
Fujita T; Epperly MW; Zou H; Greenberger JS; Wan Y
Mol Biol Cell; 2008 Dec; 19(12):5446-55. PubMed ID: 18843049
[TBL] [Abstract][Full Text] [Related]
12. Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.
Chesnokova V; Zonis S; Wawrowsky K; Tani Y; Ben-Shlomo A; Ljubimov V; Mamelak A; Bannykh S; Melmed S
Mol Endocrinol; 2012 Dec; 26(12):2092-103. PubMed ID: 23051594
[TBL] [Abstract][Full Text] [Related]
13. Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging.
Yu R; Ren SG; Horwitz GA; Wang Z; Melmed S
Mol Endocrinol; 2000 Aug; 14(8):1137-46. PubMed ID: 10935539
[TBL] [Abstract][Full Text] [Related]
14. Depletion of securin induces senescence after irradiation and enhances radiosensitivity in human cancer cells regardless of functional p53 expression.
Chen WS; Yu YC; Lee YJ; Chen JH; Hsu HY; Chiu SJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):566-74. PubMed ID: 20457353
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle dysregulation in pituitary oncogenesis.
Muşat M; Vax VV; Borboli N; Gueorguiev M; Bonner S; Korbonits M; Grossman AB
Front Horm Res; 2004; 32():34-62. PubMed ID: 15281339
[TBL] [Abstract][Full Text] [Related]
16. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis.
Zou H; McGarry TJ; Bernal T; Kirschner MW
Science; 1999 Jul; 285(5426):418-22. PubMed ID: 10411507
[TBL] [Abstract][Full Text] [Related]
17. Separase-mediated cleavage of cohesin at interphase is required for DNA repair.
Nagao K; Adachi Y; Yanagida M
Nature; 2004 Aug; 430(7003):1044-8. PubMed ID: 15329725
[TBL] [Abstract][Full Text] [Related]
18. Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression.
Wirth KG; Wutz G; Kudo NR; Desdouets C; Zetterberg A; Taghybeeglu S; Seznec J; Ducos GM; Ricci R; Firnberg N; Peters JM; Nasmyth K
J Cell Biol; 2006 Mar; 172(6):847-60. PubMed ID: 16533945
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the pituitary tumor transforming gene induces p53-dependent senescence through activating DNA damage response pathway in normal human fibroblasts.
Hsu YH; Liao LJ; Yu CH; Chiang CP; Jhan JR; Chang LC; Chen YJ; Lou PJ; Lin JJ
J Biol Chem; 2010 Jul; 285(29):22630-8. PubMed ID: 20452981
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human separase by securin binding and autocleavage.
Waizenegger I; Giménez-Abián JF; Wernic D; Peters JM
Curr Biol; 2002 Aug; 12(16):1368-78. PubMed ID: 12194817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
